Day care and treatment

Dementia: 15 key points for the caregiver

18/11/2019
Experts at Fundació ACE, aware of the impact that a dementia diagnosis has on the caregivers of the affected people, suggest taking into account some recommendations when facing the caring activity.

Merck discontinues the Verubecestat drug study

16/04/2019Research
Merck discontinued the clinical trial of the Verubecestat drug, performed by Fundació ACE in people with Alzheimer's at a very early stage, after not obtaining the expected results.

The Foundation presents the results of AMBAR at the EADC

12/04/2019Research
Fundació ACE participated this week in the biannual meeting of the European Alzheimer's Disease Consortium (EADC) to present the results of the AMBAR study, a project opening a possible new treatment pathway for Alzheimer's.

Great public attendance at the Conference of Professor Villemagne in Fundació ACE

03/04/2019Research
Around seventy Alzheimer's and dementia professionals attended yesterday at the headquarters of Fundació ACE the conference of Professor Victor L. Villemagne on molecular neuroimaging biomarkers.

Grifols presents new data to support the effectiveness of its clinical trial to treat Alzheimer's

29/03/2019Research
Dr. Mercè Boada has participated today in the presentation of the new results of the AMBAR study. These results have been presented by Dr. Antonio Páez (GRIFOLS) at the 14th International Congress on Alzheimer's and Parkinson's (AD / PD) in Lisbon.

Lecture by Professor Villemagne at Fundació ACE

20/03/2019Research
Dr. Victor L. Villemagne will visit on April 2nd Fundació ACE to offer a lecture on the current state and main trends of using biomarkers in the research of dementias and other neurodegenerative diseases.